Subcutaneous UFH Dosing for VTE Prophylaxis
The standard starting dose for subcutaneous unfractionated heparin (UFH) for VTE prophylaxis is 5000 units administered every 8 hours (three times daily). 1, 2
Dosing Recommendations Based on Clinical Setting
General Medical/Surgical Patients
- Standard prophylactic dose: 5000 units subcutaneously every 8 hours 1
- This three-times-daily regimen is more effective than twice-daily dosing in preventing DVT in general surgery patients 1, 2
- While 5000 units every 12 hours has also been used, it appears less effective, particularly in oncologic surgery 1
Pregnancy and Postpartum
- Dosing varies by trimester during pregnancy 1:
- First trimester: 5000 units subcutaneously every 12 hours
- Second trimester: 7500 units subcutaneously every 12 hours
- Third trimester: 10,000 units subcutaneously every 12 hours
- Postpartum: 5000 units subcutaneously every 8-12 hours 1
Special Populations
Patients with Renal Impairment
- UFH is the preferred agent for VTE prophylaxis in patients with severe renal dysfunction (creatinine clearance < 30 mL/min) 1, 2
- Standard dosing of 5000 units subcutaneously every 8 hours can be used without adjustment 2
- UFH is preferred over LMWH in this population because the liver is the main site of heparin biotransformation 1, 2
Obese Patients
- Limited data suggests higher doses may be needed for obese patients 3
- However, a study comparing 7500 units vs 5000 units every 8 hours in obese patients did not demonstrate a statistically significant reduction in VTE rates 3
Administration Considerations
Timing with Neuraxial Anesthesia
- First prophylactic UFH dose should be administered no sooner than 1 hour after needle/catheter placement 1
- In patients receiving preoperative prophylactic UFH, neuraxial puncture/catheter manipulation or removal should not occur within 4-6 hours after UFH administration 1
- Subsequent UFH administration may occur no earlier than 1 hour after catheter removal 1
Duration of Prophylaxis
- For medical patients: Continue for the length of hospital stay or until fully ambulatory 1
- For surgical patients: Continue for at least 7-10 days 1
- Extended prophylaxis for up to 4 weeks should be considered for high-risk patients 1, 2
Contraindications and Alternatives
- UFH is contraindicated in patients with heparin-induced thrombocytopenia (HIT) 1, 2
- For patients with a history of HIT, consider alternatives such as direct thrombin inhibitors or fondaparinux 2
- For patients at high risk of bleeding, consider mechanical prophylaxis with intermittent pneumatic compression devices 2
Monitoring
- Routine coagulation monitoring is generally not necessary for prophylactic doses of UFH 4
- There is usually no need for daily monitoring of the effect of low-dose heparin in patients with normal coagulation parameters 4
The three-times-daily regimen (5000 units every 8 hours) is preferred over twice-daily dosing because it has been shown to be more effective in preventing DVT, particularly in high-risk surgical patients, despite a potentially higher risk of bleeding complications 1.